Top Markets
#1 ICON ICON +156.44%
#2 ZetaChain ZetaChain +47.92%
#3 Four Four +39.72%
#4 Phala Phala +34.53%
#5 Chia Chia +33.77%
#6 Mubarak Mubarak +32.15%
#7 Nano Nano +27.88%
#8 SODAX SODAX +26.10%
#9 Bitway Bitway +24.95%
#10 PumpMeme PumpMeme +23.83%
Coin of the day
ICON ICON
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Classement en actions #827
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Prix de l'action
$71.46
Capitalisation boursière
$29.96B
Changement (1 jour)
-0.04%
Changement (1 an)
-51.01%
Pays
US
Échange Zoetis Inc. (ZTS)

Catégorie

Healthcare
Nombre d'actions en circulation pour Zoetis Inc. (ZTS)
Nombre d'actions en circulation au June 2026: 417.60M
Selon les derniers rapports financiers et le cours de l'action de Zoetis Inc., le nombre actuel d'actions en circulation est de 417.60M. À la fin de December 2024, l'entreprise avait 454.20M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Zoetis Inc. (ZTS) de 2009 à 2026
Actions en circulation à la fin de chaque année
Année Actions en circulation Changez
2026 (TTM) 417.60M -5.83%
2025 443.44M -2.37%
2024 454.20M -1.51%
2023 461.17M -1.65%
2022 468.89M -1.15%
2021 474.35M -0.24%
2020 475.50M -0.55%
2019 478.13M -1.02%
2018 483.06M -1.40%
2017 489.92M -1.17%
2016 495.72M -0.80%
2015 499.71M -0.27%
2014 501.06M 0.21%
2013 500.00M 0.00%
2012 500.00M 4.57%
2011 478.13M 0.00%
2010 478.13M 0.00%
2009 478.13M 0.00%
Actions en circulation pour des entreprises similaires ou concurrentes
Entreprise Actions en circulation Différence Pays
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M 113.70%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.44B 484.33%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B 324.09%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M 90.61%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 0.00 -100.00%
US